Form 4: Mary Ellen Coe Reports Merck & Co. Stock Transactions

Mary Ellen Coe, a Director at Merck & Co., Inc., has reported transactions involving phantom stock units and common stock.

Summary

• Mary Ellen Coe, a Director at Merck & Co., Inc. (MRK), has filed a Form 4 reporting changes in beneficial ownership.
• The filing details transactions on June 30, 2026, related to phantom stock units and common stock.
• Specifically, 233.463 phantom stock units were acquired, which are settled in cash upon termination of service.
• These phantom stock units are linked to 233.463 shares of common stock with a value of $128.5 per share.
• The reporting person directly beneficially owns these securities.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine compensation and ownership reporting by a director rather than a significant strategic or financial event.

Positives

• The reporting person, Mary Ellen Coe, directly holds securities, indicating direct beneficial ownership.
• Phantom stock units are structured for cash settlement upon termination, providing a clear payout mechanism.

Negatives

• The filing does not disclose any negative financial performance or operational issues.

Risks

• The value of phantom stock units is tied to the stock price, meaning a decline in Merck & Co.'s stock price would reduce the value of these units.
• The settlement of phantom stock units is contingent upon the reporting person's termination of service.

Future Outlook

The phantom stock units are to be settled in cash upon the reporting person's termination of service, according to a distribution schedule elected under the Plan for Deferred Payment of Directors' Compensation.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company directors and officers. This specific filing indicates a standard compensation-related transaction for a director.

Stakeholder Impact

• Shareholders gain transparency into director compensation and ownership through this disclosure.
• Employees may view this as a standard component of executive and director compensation packages.

Next Steps

• Settlement of phantom stock units in cash upon reporting person's termination of service.

Key Dates

Keywords

Form 4, SEC Filing, Merck & Co., MRK, Mary Ellen Coe, Director, Beneficial Ownership, Phantom Stock, Common Stock, Insider Trading